Trademarkia Logo

Australia

AU$
Trademark Search
OPDUALAG (NIVOLUMAB/RELATIMAB)

View On IPO.GOV.AU

OPDUALAG (NIVOLUMAB/RELATIMAB)
Registered: Registered/protected

Last updated on 19 Oct 2023

Owner Info

Bristol-Myers Squibb Company incorporated in the State of Delaware

Route 206 & Province Line Road

Princeton, New Jersey 08543, UNITED STATES OF AMERICA

Serial Number

2113368 filed on 20 Aug 2020

Correspondent

Spruson & Ferguson

GPO Box 3898,

Sydney, NSW, 2001 AUSTRALIA,

OPDUALAG (NIVOLUMAB/RELATIMAB)

Classification Information

Class [005]
Pharmaceutical preparations for human use.

Class [044]
Health care services, namely, providing information to physicians, health care professionals and patients on the topic of health issues, health awaren Read More

Mark Details

Serial Number

2113368

Registered On

20 Aug 2020

Renewal On

20 Aug 2030

Mark Type

FIGURATIVE

Priority Claim (Convention Details)

Date

21 Feb 2020

Mark Type

US

Legal History

Show more

Status DateAction Taken
19th Oct 2023Customer Amendment Made correspondence sent
19th Oct 2023Owner name details updated
6th Oct 2023Amendment to Amend Owner Requested
26th Mar 2021IP Right Registered correspondence sent
25th Mar 2021IP Right Registration Published
25th Mar 2021Status change to Registered/Protected
18th Jan 2021Application Accepted correspondence sent
18th Jan 2021IP Right has been Examined
18th Jan 2021IP Right Acceptance Published
18th Jan 2021Status change to Accepted